An Indian drugmaker, once under the microscope of ProPublica, has announced a recall of two dozen medications that were sent to patients across the U.S. This alarming development has sparked fresh concerns about the safety and quality of drugs, especially in light of previous investigations that uncovered troubling issues within the company.
In a dramatic turn of events, Panama has moved to regulate cannabis, opening doors for its medicinal use. Meanwhile, Italy has opted for a ban, reversing previous progress. This juxtaposition highlights the varied global approaches to cannabis legislation.
A recent investigation by BBC reveals that an Indian pharmaceutical company is significantly contributing to West Africa’s escalating opioid crisis. The report highlights alarming practices, including the production and distribution of potent opioids, raising concerns about public health and regulatory oversight in the region.
